![]() |
![]() |
![]() |
| Vol.
4, No. 2, May 26, 2005
| To The Editor
| Subscribe | Back
Issues |
MeasuresOfSuccess.com | Masthead |
Advisory Board | Reprint
Information | |
||
|
Can this reputation be saved?
by Katie Delahaye Paine You know you're in trouble when the blogs ridicule you within hours of an announcement. Which is just what happened when Billy Tauzin (former Louisiana Congressman and now CEO and spokesperson for PhRMA, the pharmaceutical industry trade group) spoke to the press this week. Clearly he was trying for mea culpa, admitting publicly that his industry had a "negative image" that wouldn't be turned around over night, but he didn't pull it off. The real question is: Can the industry's reputation be turned around at all? We say probably not. First of all, Tauzin himself has a credibility problem worse than a bad drug habit. He jumped from the legislature, where he was well known for protecting the interests of the pharmaceuticals, to the PhRMA job, where he now makes $2 million a year. Add to that the fact that Tauzin was one of those who helped push through the controversial Medicare Prescription Drug bill, which is widely seen as favoring the industry at the (very large) expense of taxpayers. His apparent penchant for stretching the truth doesn't help either: Tauzin told the media that the importation of less expensive drugs from Canada (something the majority of the American people now favor) could aid Al-Qaeda. Go figure. This is not a man endearing himself to the public or the media. What was PhRMA thinking? Why would they hire someone whose reputation is questionable to fix their own tarnished image? Why not hire someone the media is going to trust? And if you are going to put yourself in front of the media, perhaps you should do a quick credibility check before you start making the Al-Qaeda connection. Just because the President can get it away with it, doesn't mean everyone can. The press and the blogosphere found such claims ridiculous, and that's not going to help build trust with the public. Finally, the industry has to address its fundamental problem: the high price of pharmaceuticals. Most of America is on some kind of prescription drug and if you don't have insurance, you're paying a very hefty price. Until we start seeing the price of drugs go down, all the image polishing and press conferences aren't going to help. Tauzin did say that the industry was working to get more affordable drugs to the people that need them. But there are an awful lot of influential people, including journalists and bloggers, who won't believe it till they see it in their own wallets. And Tauzin's $2 million paycheck does nothing to convince us of the industry's commitment to the average American's well-being. As we've been saying for years, it takes a lot of good deeds to change a tarnished image, and no matter how many press conferences you have, the image won't change until those deeds start to accumulate for the media and the influentials to notice. Here is Dr. Paine's prescription for reputation repair:
So maybe,
if the pharmaceutical industry started a course of radical therapy right
now, they might be able to turn around their image by 2010. But my guess
is that it would be too big a pill for them to swallow. |
|
|||
|
New!
A State-of-the Art |
Three Reasons Why You Should Subscribe to The Measurement Standard: 1. Youll learn how to use hard numbers to prove the results of your PR efforts. 2. Youll learn which are the right vendors for your measurement projects. 3. Youll learn how to design your program right from the start to be easily measureable. Click
here to |
|||
|
Sign up now for your free monthly One-Minute Benchmarking Bulletin and stay up to date on PR and marketing measurement around the world. Just send us an email with "subscribe" in the subject line. |
||||
|
|
|
|||
|
|
||||
|
|
||||
|
51 Durham Point Road, Durham, NH 03824 |
|||